Delaware
|
001-34637
|
20-1852016
|
||
(State or Other Jurisdiction of
Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer
Identification No.)
|
25801 Industrial Boulevard, Suite B, Hayward,
California
|
94545
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Item 5.02
|
Compensatory Arrangements of Certain Officers.
|
Named Executive Officer
|
Effective
April 1, 2014
|
Effective
April 1, 2015
|
$ Change
|
|||||||||
Paul F. Truex, President and Chief Executive Officer
|
$ | 515,000 | $ | 450,000 | $ | (65,000 | ) | |||||
Colin Hislop, M.D., Senior Vice President and Chief Medical Officer
|
$ | 350,000 | $ | 360,000 | $ | 10,000 | ||||||
Debra Odink, Ph.D., Senior Vice President and Chief Technology Officer
|
$ | 340,000 | $ | 355,000 | $ | 15,000 | ||||||
Klara Dickinson, Senior Vice President and Chief Regulatory Officer (1)
|
$ | - | $ | 325,000 | $ | - | ||||||
May Liu, Senior Vice President, Finance and Administration
|
$ | 261,000 | $ | 286,000 | $ | 25,000 |
(1)
|
Ms. Dickinson joined the company as Senior Vice President, Chief Regulatory Officer on January 5, 2015.
|
Date: April 8, 2015
|
Anthera Pharmaceuticals, Inc.
|
|
By:
|
/s/ May Liu
|
|
May Liu
|
||
Principal Accounting Officer
|